These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24616018)

  • 1. Characterization of rotavirus genotypes before and after the introduction of a monovalent rotavirus vaccine in Colombia.
    Peláez-Carvajal D; Cotes-Cantillo K; Paternina-Caicedo A; Gentsch J; de la Hoz-Restrepo F; Patel M
    J Med Virol; 2014 Jun; 86(6):1083-6. PubMed ID: 24616018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.
    Hull JJ; Teel EN; Kerin TK; Freeman MM; Esona MD; Gentsch JR; Cortese MM; Parashar UD; Glass RI; Bowen MD;
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S42-7. PubMed ID: 21183839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.
    Guerra SF; Linhares AC; Mascarenhas JD; Oliveira A; Justino MC; Soares LS; Müller EC; Brasil P; Tuboi S; Ortega-Barria E; Colindres R
    J Med Virol; 2015 Aug; 87(8):1303-10. PubMed ID: 25879653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of rotavirus strains circulating in Northern Brazil after introduction of a rotavirus vaccine: high prevalence of G3P[6] genotype.
    da Silva Soares L; de Fátima Dos Santos Guerra S; do Socorro Lima de Oliveira A; da Silva Dos Santos F; de Fátima Costa de Menezes EM; Mascarenhas Jd; Linhares AC
    J Med Virol; 2014 Jun; 86(6):1065-72. PubMed ID: 24136444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
    Kirkwood CD; Boniface K; Barnes GL; Bishop RF
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S48-53. PubMed ID: 21183840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of group A rotavirus infection after the introduction of monovalent vaccine in the National Immunization Program of Saudi Arabia.
    Al-Ayed MS; Asaad AM; Qureshi MA; Hawan AA
    J Med Virol; 2017 Mar; 89(3):429-434. PubMed ID: 27531633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses.
    Matthijnssens J; Zeller M; Heylen E; De Coster S; Vercauteren J; Braeckman T; Van Herck K; Meyer N; Pirçon JY; Soriano-Gabarro M; Azou M; Capiau H; De Koster J; Maernoudt AS; Raes M; Verdonck L; Verghote M; Vergison A; Van Damme P; Van Ranst M;
    Clin Microbiol Infect; 2014 Oct; 20(10):O702-10. PubMed ID: 24580887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and genomic characterization of G2P[4] group A rotavirus strains during monovalent vaccine introduction in Brazil.
    Gómez MM; Carvalho-Costa FA; Volotão Ede M; Rose TL; da Silva MF; Fialho AM; Assis RM; de Andrade Jda S; Sá AC; Zeller M; Heylen E; Matthijnssens J; Leite JP
    Infect Genet Evol; 2014 Dec; 28():486-94. PubMed ID: 25239525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of human rotaviruses in 2007-2011, Hungary: exploring the genetic relatedness between vaccine and field strains.
    László B; Kónya J; Dandár E; Deák J; Farkas Á; Gray J; Grósz G; Iturriza-Gomara M; Jakab F; Juhász Á; Kisfali P; Kovács J; Lengyel G; Martella V; Melegh B; Mészáros J; Molnár P; Nyúl Z; Papp H; Pátri L; Puskás E; Sántha I; Schneider F; Szomor K; Tóth A; Tóth E; Szűcs G; Bányai K
    J Clin Virol; 2012 Oct; 55(2):140-6. PubMed ID: 22841750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-based surveillance and analysis of genotype variation in Nicaragua after the introduction of the pentavalent rotavirus vaccine.
    Khawaja S; Cardellino A; Mast TC
    Pediatr Infect Dis J; 2014 Jan; 33(1):e25-8. PubMed ID: 24042492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Rotavirus Genotypes before and after Vaccine Introduction: a Multicenter, Prospective Observational Study in Three Areas of Japan.
    Tanaka T; Kamiya H; Asada K; Suga S; Ido M; Umemoto M; Ouchi K; Ito H; Kuroki H; Nakano T; Taniguchi K
    Jpn J Infect Dis; 2017 Jul; 70(4):448-452. PubMed ID: 28250254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of G12P[8] rotavirus strains in Rio Branco, Acre, Western Amazon, in the post-rotavirus vaccine introduction period.
    Neves MA; Pinheiro HH; Silva RS; Linhares AC; Silva LD; Gabbay YB; Silva MC; Loureiro EC; Soares LS; Mascarenhas JD
    J Med Virol; 2016 May; 88(5):782-9. PubMed ID: 26466923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study.
    Ichihara MY; Rodrigues LC; Teles Santos CA; Teixeira Mda G; De Jesus SR; Alvim De Matos SM; Gagliardi Leite JP; Barreto ML
    Vaccine; 2014 May; 32(23):2740-7. PubMed ID: 24508336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of reassortant G9P[4] rotavirus strain in Bangladesh: fully heterotypic from vaccine strains.
    Afrad MH; Rahman MZ; Matthijnssens J; Das SK; Faruque AS; Azim T; Rahman M
    J Clin Virol; 2013 Dec; 58(4):755-6. PubMed ID: 24144673
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of G2P[4] rotavirus strains associated with increased detection in Australian states using the RotaTeq® vaccine during the 2010-2011 surveillance period.
    Donato CM; Zhang ZA; Donker NC; Kirkwood CD
    Infect Genet Evol; 2014 Dec; 28():398-412. PubMed ID: 24861815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of rotavirus genotypes after vaccine introduction in the Triângulo Mineiro region of Brazil: 4-Year follow-up study.
    Dulgheroff AC; Figueiredo EF; Moreira LP; Moreira KC; Moura LM; Gouvêa VS; Domingues AL
    J Clin Virol; 2012 Sep; 55(1):67-71. PubMed ID: 22795600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.
    Carvalho-Costa FA; Volotão Ede M; de Assis RM; Fialho AM; de Andrade Jda S; Rocha LN; Tort LF; da Silva MF; Gómez MM; de Souza PM; Leite JP
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S35-41. PubMed ID: 21048523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of group A Rotavirus in Buenos Aires 2008-2011, long lasting circulation of G2P[4] strains possibly linked to massive monovalent vaccination in the region.
    Mandile MG; Esteban LE; Argüelles MH; Mistchenko A; Glikmann G; Castello AA
    J Clin Virol; 2014 Jul; 60(3):282-9. PubMed ID: 24875137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.
    Roczo-Farkas S; Kirkwood CD; Cowley D; Barnes GL; Bishop RF; Bogdanovic-Sakran N; Boniface K; Donato CM; Bines JE
    J Infect Dis; 2018 Jul; 218(4):546-554. PubMed ID: 29790933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of rotavirus G2P[4] and emergence of G12P[9] strains in Asunción, Paraguay, 2006-2007.
    Martínez M; Amarilla AA; Galeano ME; Aquino VH; Fariña N; Russomando G; Parra GI
    Arch Virol; 2010 Apr; 155(4):525-33. PubMed ID: 20213281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.